Summit X, LLC Danaher Corp Transaction History

Summit X, LLC

$423 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$224.99 - $256.14 $501,502 - $570,936	-2,229 Reduced 42.32%	3,038 $729,000
Q1 2023 May 10, 2023	BUY	$239.75 - $277.0 $1,678 - $1,939	7 Added 0.13%	5,267 $1.33 Million
Q4 2022 Feb 02, 2023	SELL	$241.42 - $282.29 $54,560 - $63,797	-226 Reduced 4.12%	5,260 $1.4 Million
Q3 2022 Nov 01, 2022	BUY	$247.06 - $1507.4 $55,588 - $339,165	225 Added 4.28%	5,486 $1.41 Million
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $17,546 - $22,174	-74 Reduced 1.39%	5,261 $1.33 Million
Q1 2022 May 05, 2022	BUY	$257.27 - $315.76 $11,834 - $14,524	46 Added 0.87%	5,335 $1.57 Million
Q4 2021 Jan 19, 2022	SELL	$292.08 - $329.01 $20,445 - $23,030	-70 Reduced 1.31%	5,289 $1.74 Million
Q3 2021 Oct 19, 2021	SELL	$272.21 - $332.43 $14,971 - $18,283	-55 Reduced 1.02%	5,359 $1.63 Million
Q2 2021 Jul 16, 2021	SELL	$225.08 - $271.69 $16,881 - $20,376	-75 Reduced 1.37%	5,414 $1.45 Million
Q1 2021 May 10, 2021	SELL	$212.38 - $245.9 $25,485 - $29,508	-120 Reduced 2.14%	5,489 $1.24 Million
Q4 2020 Jan 29, 2021	SELL	$212.5 - $245.46 $60,562 - $69,956	-285 Reduced 4.84%	5,609 $1.25 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $17,374 - $23,872	135 Added 2.34%	5,894 $1.04 Million
Q1 2020 May 13, 2020	BUY	$121.39 - $169.05 $9,711 - $13,524	80 Added 1.41%	5,759 $800,000
Q4 2019 Jan 23, 2020	BUY	$133.47 - $153.48 $36,036 - $41,439	270 Added 4.99%	5,679 $874,000
Q3 2019 Oct 15, 2019	BUY	$135.4 - $146.47 $15,571 - $16,844	115 Added 2.17%	5,409 $786,000
Q2 2019 Aug 13, 2019	SELL	$124.88 - $143.73 $113,640 - $130,794	-910 Reduced 14.67%	5,294 $755,000
Q1 2019 May 13, 2019	BUY	$97.62 - $132.29 $81,512 - $110,462	835 Added 15.55%	6,204 $820,000
Q4 2018 Feb 13, 2019	BUY	$94.85 - $109.54 $175,851 - $203,087	1,854 Added 52.75%	5,369 $551,000
Q3 2018 Nov 01, 2018	SELL	$98.13 - $108.9 $13,738 - $15,246	-140 Reduced 3.83%	3,515 $427,000
Q2 2018 Sep 24, 2018	SELL	$96.1 - $103.24 $57,852 - $62,150	-602 Reduced 14.14%	3,655 $356,000
Q2 2018 Aug 13, 2018	BUY	$96.1 - $103.24 $66,020 - $70,925	687 Added 19.24%	4,257 $356,000
Q1 2018 May 23, 2018	SELL	$92.16 - $103.8 $921 - $1,038	-10 Reduced 0.28%	3,570 $349,000
Q4 2017 Jan 23, 2018	BUY	$85.26 - $94.62 $5,115 - $5,677	60 Added 1.7%	3,580 $334,000
Q3 2017 Oct 17, 2017	BUY	$79.29 - $88.45 $33,698 - $37,591	425 Added 13.73%	3,520 $300,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,095	3,095 $262,000

Others Institutions Holding DHR

# of Institutions

2,510

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

Vanguard Group Inc Valley Forge, PA

59.4M
Shares

$14.2 Billion
0.3% of portfolio
Black Rock Inc. New York, NY

50.5M
Shares

$12.1 Billion
0.29% of portfolio
State Street Corp Boston, MA

27.5M
Shares

$6.56 Billion
0.32% of portfolio
Wellington Management Group LLP Boston, MA

23.3M
Shares

$5.57 Billion
1.16% of portfolio
Price T Rowe Associates Inc Baltimore, MD

20.5M
Shares

$4.89 Billion
0.66% of portfolio

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $174B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Account